Trends in <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) Bacteremia during the COVID-19 Pandemic: A Systematic Review

<i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) is among the most common pathogens associated with healthcare-acquired infections, and is often antibiotic resistant, causing significant morbidity and mortality in cases of <i>P. aeruginosa</i> bacteremia. It r...

Full description

Saved in:
Bibliographic Details
Main Authors: Qin Xiang Ng (Author), Natasha Yixuan Ong (Author), Dawn Yi Xin Lee (Author), Chun En Yau (Author), Yu Liang Lim (Author), Andrea Lay Hoon Kwa (Author), Ban Hock Tan (Author)
Format: Book
Published: MDPI AG, 2023-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_dbd0b26cbf914f5a90c2566c01a64b14
042 |a dc 
100 1 0 |a Qin Xiang Ng  |e author 
700 1 0 |a Natasha Yixuan Ong  |e author 
700 1 0 |a Dawn Yi Xin Lee  |e author 
700 1 0 |a Chun En Yau  |e author 
700 1 0 |a Yu Liang Lim  |e author 
700 1 0 |a Andrea Lay Hoon Kwa  |e author 
700 1 0 |a Ban Hock Tan  |e author 
245 0 0 |a Trends in <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) Bacteremia during the COVID-19 Pandemic: A Systematic Review 
260 |b MDPI AG,   |c 2023-02-01T00:00:00Z. 
500 |a 10.3390/antibiotics12020409 
500 |a 2079-6382 
520 |a <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) is among the most common pathogens associated with healthcare-acquired infections, and is often antibiotic resistant, causing significant morbidity and mortality in cases of <i>P. aeruginosa</i> bacteremia. It remains unclear how the incidence of <i>P. aeruginosa</i> bacteremia changed during the Coronavirus Disease 2019 (COVID-19) pandemic, with studies showing almost contradictory conclusions despite enhanced infection control practices during the pandemic. This systematic review sought to examine published reports with incidence rates for <i>P. aeruginosa</i> bacteremia during (defined as from March 2020 onwards) and prior to the COVID-19 pandemic. A systematic literature search was conducted in accordance with PRISMA guidelines and performed in Cochrane, Embase, and Medline with combinations of the key words (pseudomonas aeruginosa OR PAE) AND (incidence OR surveillance), from database inception until 1 December 2022. Based on the pre-defined inclusion criteria, a total of eight studies were eligible for review. Prior to the pandemic, the prevalence of <i>P. aeruginosa</i> was on an uptrend. Several international reports found a slight increase in the incidence of <i>P. aeruginosa</i> bacteremia during the COVID-19 pandemic. These findings collectively highlight the continued importance of good infection prevention and control and antimicrobial stewardship during both pandemic and non-pandemic periods. It is important to implement effective infection prevention and control measures, including ensuring hand hygiene, stepping up environmental cleaning and disinfection efforts, and developing timely guidelines on the appropriate prescription of antibiotics. 
546 |a EN 
690 |a <i>P. aeruginosa</i> 
690 |a COVID-19 
690 |a collateral effect 
690 |a antibiotics 
690 |a antimicrobial stewardship 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antibiotics, Vol 12, Iss 2, p 409 (2023) 
787 0 |n https://www.mdpi.com/2079-6382/12/2/409 
787 0 |n https://doaj.org/toc/2079-6382 
856 4 1 |u https://doaj.org/article/dbd0b26cbf914f5a90c2566c01a64b14  |z Connect to this object online.